Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease.

Bao YS, Ji Y, Zhao SL, Ma LL, Xie RJ, Na SP.

Biomarkers. 2013 Aug;18(5):379-85. doi: 10.3109/1354750X.2013.790074. Epub 2013 May 7.

PMID:
23651343
2.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.

Nephrol Dial Transplant. 2009 Jun;24(6):1901-8. doi: 10.1093/ndt/gfn739. Epub 2009 Jan 20.

PMID:
19155537
3.

Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.

Suzuki Y, Suda T, Yokomura K, Suzuki M, Fujie M, Furuhashi K, Hahimoto D, Enomto N, Fujisawa T, Nakamura Y, Inui N, Nakano Y, Nakamura H, Chida K.

J Infect. 2011 Sep;63(3):215-22. doi: 10.1016/j.jinf.2011.07.003. Epub 2011 Jul 19.

PMID:
21784100
4.

Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.

de Jong RA, Nijman HW, Boezen HM, Volmer M, Ten Hoor KA, Krijnen J, van der Zee AG, Hollema H, Kema IP.

Int J Gynecol Cancer. 2011 Oct;21(7):1320-7. doi: 10.1097/IGC.0b013e31822017fb.

PMID:
21720257
5.

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.

Suzuki Y, Suda T, Furuhashi K, Suzuki M, Fujie M, Hahimoto D, Nakamura Y, Inui N, Nakamura H, Chida K.

Lung Cancer. 2010 Mar;67(3):361-5. doi: 10.1016/j.lungcan.2009.05.001. Epub 2009 May 31.

PMID:
19487045
6.

Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.

Munipally PK, Agraharm SG, Valavala VK, Gundae S, Turlapati NR.

Arch Physiol Biochem. 2011 Dec;117(5):254-8. doi: 10.3109/13813455.2011.623705. Epub 2011 Oct 29.

PMID:
22034910
7.

Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.

Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D.

Clin Sci (Lond). 2009 Apr;116(7):593-8. doi: 10.1042/CS20080319.

PMID:
18986303
8.

Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia.

Wang CY, Shi Y, Min YN, Zhu XJ, Guo CS, Peng J, Dong XY, Qin P, Sun JZ, Hou M.

J Clin Immunol. 2011 Aug;31(4):643-9. doi: 10.1007/s10875-011-9525-7. Epub 2011 Apr 13.

PMID:
21487895
9.

Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease.

Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G.

Endocrine. 2009 Aug;36(1):119-25. doi: 10.1007/s12020-009-9184-0. Epub 2009 Apr 11.

PMID:
19363598
10.

Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.

Zinellu A, Sotgia S, Mangoni AA, Sanna M, Satta AE, Carru C.

Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):153-9. doi: 10.1016/j.numecd.2014.11.004. Epub 2014 Nov 22.

PMID:
25534866
11.

Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis.

Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, Fujie M, Furuhashi K, Nakamura Y, Inui N, Shirai T, Hayakawa H, Nakamura H, Chida K.

Clin Vaccine Immunol. 2012 Mar;19(3):436-42. doi: 10.1128/CVI.05402-11. Epub 2012 Jan 4.

12.

Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.

Pertovaara M, Raitala A, Uusitalo H, Pukander J, Helin H, Oja SS, Hurme M.

Clin Exp Immunol. 2005 Oct;142(1):155-61.

13.

High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.

Huttunen R, Syrjänen J, Aittoniemi J, Oja SS, Raitala A, Laine J, Pertovaara M, Vuento R, Huhtala H, Hurme M.

Shock. 2010 Feb;33(2):149-54. doi: 10.1097/SHK.0b013e3181ad3195.

PMID:
19487973
14.

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.

Pertovaara M, Hasan T, Raitala A, Oja SS, Yli-Kerttula U, Korpela M, Hurme M.

Clin Exp Immunol. 2007 Nov;150(2):274-8. Epub 2007 Aug 17.

15.

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM.

Blood. 2005 Feb 15;105(4):1574-81. Epub 2004 Oct 5.

16.

Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation.

Yilmaz N, Ustundag Y, Kivrak S, Kahvecioglu S, Celik H, Kivrak I, Huysal K.

Ren Fail. 2016 Sep;38(8):1300-9. doi: 10.1080/0886022X.2016.1209389. Epub 2016 Jul 27.

PMID:
27466137
17.

Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke.

Mo X, Pi L, Yang J, Xiang Z, Tang A.

J Clin Neurosci. 2014 Mar;21(3):482-6. doi: 10.1016/j.jocn.2013.08.020. Epub 2013 Oct 30.

PMID:
24412293
18.

Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.

Brandacher G, Cakar F, Winkler C, Schneeberger S, Obrist P, Bösmüller C, Werner-Felmayer G, Werner ER, Bonatti H, Margreiter R, Fuchs D.

Kidney Int. 2007 Jan;71(1):60-7. Epub 2006 Nov 15.

19.

[Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].

Sakurai K, Matsuo S, Enomoto K, Tani M, Kitajima A, Amano S.

Gan To Kagaku Ryoho. 2009 Nov;36(12):1991-3. Japanese.

PMID:
20037301
20.

Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children.

Buyuktiryaki B, Sahiner UM, Girgin G, Birben E, Soyer OU, Cavkaytar O, Cetin C, Arik Yilmaz E, Yavuz ST, Kalayci O, Baydar T, Sackesen C.

Allergy. 2016 Feb;71(2):258-66. doi: 10.1111/all.12785. Epub 2015 Nov 26.

Supplemental Content

Support Center